AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H241-H250, 2003. First published March 13, 2003; doi:10.1152/ajpheart.00018.2003
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/H241    most recent
00018.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ospina, J. A.
Right arrow Articles by Krause, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ospina, J. A.
Right arrow Articles by Krause, D. N.

17{beta}-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation

Jose A. Ospina, Sue P. Duckles, and Diana N. Krause

Department of Pharmacology, College of Medicine, University of California, Irvine, California 92697-4625

Submitted 8 January 2003 ; accepted in final form 9 March 2003

We have previously shown that estrogen treatment increases cerebrovascular cyclooxygenase-1, prostacyclin synthase, and production of prostacyclin. Therefore, vascular tone and prostanoid production were measured to investigate functional consequences of estrogen exposure. Middle cerebral arteries were isolated from ovariectomized female Fischer-344 rats with or without chronic in vivo 17{beta}-estradiol treatment. In vivo 17{beta}-estradiol treatment increased cerebral artery diameter; functional endothelium was required for expression of these differences. The nonspecific cyclooxygenase inhibitor indomethacin constricted, whereas arachidonic acid dilated, cerebral arteries from estrogen-treated animals. Estrogen exposure increased production of prostacyclin by cerebral arteries. Conversely, in estrogen-deficient animals, indomethacin dilated and arachidonic acid constricted cerebral blood vessels. This correlated with vasorelaxation following inhibition of the thromboxane-endoperoxide receptor with SQ-29548 but not after selective blockade of thromboxane synthase with furegrelate, suggesting prostaglandin endoperoxide (i.e., PGH2) activity. Removal of the endothelium or selective blockade of cyclooxygenase-1 with SC-560 abolished estrogen-mediated differences in the effects of arachidonate on vessel diameter and on prostacyclin production by cerebral arteries. These data suggest 17{beta}-estradiol decreases cerebrovascular tone by shifting the primary end product of the endothelial cyclooxygenase-1 pathway from the constrictor prostaglandin PGH2 to the vasodilator prostacyclin. These effects of estrogen may contribute to the heightened thromboresistance and enhanced cerebral blood flow documented in preversus postmenopausal women.

cyclooxygenase; prostacyclin; prostaglandin endoperoxide



Address for reprint requests and other correspondence: D. N. Krause, Dept. of Pharmacology, College of Medicine, Univ. of California, Irvine, CA 92697-4625 (E-mail: dnkrause{at}uci.edu).




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. L. Hodnett, J. A. Dearman, C. B. Carter, and R. L. Hester
Attenuated PGI2 synthesis in obese Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R715 - R721.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
P. D. Patel and R. R. Arora
Review: Endothelial dysfunction: A potential tool in gender related cardiovascular disease
Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 89 - 100.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Girouard, A. Lessard, C. Capone, T. A. Milner, and C. Iadecola
The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H156 - H163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. E. Bearden
Advancing age produces sex differences in vasomotor kinetics during and after skeletal muscle contraction
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1274 - R1279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Sunday, C. Osuna, D. N. Krause, and S. P. Duckles
Age alters cerebrovascular inflammation and effects of estrogen
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2333 - H2340.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. N. Krause, S. P. Duckles, and D. A. Pelligrino
Influence of sex steroid hormones on cerebrovascular function
J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. M. Faraci
Reactive oxygen species: influence on cerebral vascular tone
J Appl Physiol, February 1, 2006; 100(2): 739 - 743.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
S. P. Duckles, D. N. Krause, C. Stirone, and V. Procaccio
Estrogen and mitochondria: a new paradigm for vascular protection?
Mol. Interv., February 1, 2006; 6(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Andresen, N. I. Shafi, and R. M. Bryan Jr.
Endothelial influences on cerebrovascular tone
J Appl Physiol, January 1, 2006; 100(1): 318 - 327.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Hermenegildo, P.J. Oviedo, M.C. Garcia-Martinez, M.A. Garcia-Perez, J.J. Tarin, and A. Cano
Progestogens stimulate prostacyclin production by human endothelial cells
Hum. Reprod., June 1, 2005; 20(6): 1554 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
D. Korita, H. Itoh, N. Sagawa, S. Yura, M. Yoshida, K. Kakui, M. Takemura, and S. Fujii
17{beta}-Estradiol Up-Regulates Prostacyclin Production in Cultured Human Uterine Myometrial Cells Via Augmentation of Both Cyclooxygenase-1 and Prostacyclin Synthase Expression
Reproductive Sciences, October 1, 2004; 11(7): 457 - 464.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Li, G. G. Geary, R. J. Gonzales, D. N. Krause, and S. P. Duckles
Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H588 - H594.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Ospina, H. N. Brevig, D. N. Krause, and S. P. Duckles
Estrogen suppresses IL-1{beta}-mediated induction of COX-2 pathway in rat cerebral blood vessels
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H2010 - H2019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Gonzales, D. N. Krause, and S. P. Duckles
Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H552 - H560.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.